The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Bexion
Research Funding - Bexion; IMV; Kyowa Kirin; Nanobiotix; Oxford BioTherapeutics; Processa Pharmaceuticals; RAPT Therapeutics; Rgenix
Phase 1 study of OBT076, a first-in-class anti-DEC205 ADC, in patients with advanced/metastatic solid tumors: Safety, efficacy, and PK/PD results.
 
Olivier Rixe
No Relationships to Disclose
 
Shou-Ching Tang
No Relationships to Disclose
 
Solmaz Sahebjam
Stock and Other Ownership Interests - Abbvie
Consulting or Advisory Role - Boehringer Ingelheim; Merck
Research Funding - Bristol-Myers Squibb (Inst); Brooklyn ImmunoTherapeutics (Inst); Merck (Inst)
 
Monica M. Mita
Research Funding - Seagen (Inst)
 
Alain C. Mita
Speakers' Bureau - Genentech
 
Lee S. Rosen
Research Funding - Bayer (Inst); Pfizer (Inst); PsiOxus Therapeutics (Inst); Rgenix (Inst)
 
Arnima Bisht
Employment - Oxford BioTherapeutics
Stock and Other Ownership Interests - Oxford BioTherapeutics
 
Abderrahim Fandi
Employment - Oxford Biotherapeutics
Stock and Other Ownership Interests - Oxford Biotherapeutics
 
Christian Rohlff
Employment - Oxford BioTherapeutics
Stock and Other Ownership Interests - Oxford BioTherapeutics
 
Rutika Mehta
Honoraria - Bristol-Myers Squibb; NCCN; NCCN/Pfizer (I); Pfizer/EMD Serono (I)
Consulting or Advisory Role - Bristol-Myers Squibb; Bristol-Myers Squibb (I); Lilly
Speakers' Bureau - Daiichi Sankyo; Gilead Sciences (I); Natera; Seagen (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb